Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

An Interventional Safety Switch Study (Segue Study) of XYWAV in Narcolepsy

ClinicalTrials.gov ID: NCT04794491

Public ClinicalTrials.gov record NCT04794491. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 5:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 4 Multicenter, Open-label, Single-arm Study of Safety, Tolerability, Effectiveness and Treatment Optimization in Participants Switching From Xyrem to XYWAV for the Treatment of Narcolepsy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The rationale for the interventional, open-label, single-arm design of JZP258-401 is to evaluate the clinical experience in participants with narcolepsy transitioning treatment from Xyrem to XYWAV.

Study identification

NCT ID
NCT04794491
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Jazz Pharmaceuticals
Industry
Enrollment
62 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 21, 2021
Primary completion
Nov 14, 2022
Completion
Nov 14, 2022
Last update posted
Jan 8, 2024

2021 – 2022

United States locations

U.S. sites
28
U.S. states
14
U.S. cities
25
Facility City State ZIP Site status
Wright Clinical Research, LLC Alabaster Alabama 35007
Sleep Disorders Center of Alabama Birmingham Alabama 35213
Pulmonary Associates of the Southeast, PC Birmingham Alabama 35254
Santa Monica Clinical Trials Los Angeles California 90025
Southern California Institute For Respiratory Diseases, Inc./ Tower Sleep Medicine Los Angeles California 90048
Southern California Institute For Respiratory Diseases, Inc. Los Angeles California 90048
Stanford University- Sleep Medicine Redwood City California 94063
SDS Clinical Trials, Inc Santa Ana California 92705
Delta Waves, Inc. Colorado Springs Colorado 80918
Pulmonary Disease Specialists, PA d/b/a PDS Research Kissimmee Florida 34741
Clinical Research of West Florida, Inc Tampa Florida 33606
Florida Pediatric Research Institute, LLC Winter Park Florida 32789
Sleep Practitioners LLC Macon Georgia 31210
Clinical Research Institute Stockbridge Georgia 30281
The Center for Sleep & Wake Disorders Chevy Chase Maryland 20815
WMed Center for Clinical Research Kalamazoo Michigan 49008
Minnesota Lung Center Edina Minnesota 55435
Clayton Sleep Institute, LLC St Louis Missouri 63123
Clinical Research of Gastonia Gastonia North Carolina 28054
Intrepid Research LLC Cincinnati Ohio 45245
Cleveland Clinic, Sleep Disorders Center Cleveland Ohio 44195
Ohio Sleep Medicine Institute Dublin Ohio 43017
Geisinger Clinic Danville Pennsylvania 17822
Bogan Sleep Consultants, LLC Columbia South Carolina 29201
Medical University of South Carolina, Department of Psychiatry and Behavioral Sciences North Charleston South Carolina 29425
Clinical Research of Rock Hill Rock Hill South Carolina 29732
FutureSearch Trials of Neurology Austin Texas 78731
Sleep Therapy & Research Center San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04794491, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 8, 2024 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04794491 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →